Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Cellular respiration Stories

2013-03-25 04:22:24

LUND, Sweden, March 25, 2013 /PRNewswire/ -- NeuroVive, a leading mitochondrial medicine company, announces that its shares have been approved for listing on NASDAQ OMX Stockholm by the exchange's Listing Committee. The first day of trading on NASDAQ OMX Stockholm will be April 10th and the last day of trading on the Swedish trading platform AktieTorget will be April 9th. The stock will be traded under the same ticker symbol, NVP. No new shares will be issued in...

2013-03-18 08:27:51

LUND, Sweden, March 18, 2013 /PRNewswire/ -- NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company announces that Anna Malm Bernsten and Boel Flodgren have been elected to the Company's Board. Both have exceptional track records and leadership experience and are expected to make a significant contribution to NeuroVive. Anna Malm Bernsten has more than 25 years of international marketing and sales experience in the healthcare industry. She was until...

2013-03-11 14:56:39

Protein activity is strictly regulated. Incorrect or poor protein regulation can lead to uncontrolled growth and thus cancer or chronic inflammation. Members of the Institute of Veterinary Biochemistry and Molecular Biology from the University of Zurich have identified enzymes that can regulate the activity of medically important proteins. Their discovery enables these proteins to be manipulated very selectively, opening up new treatment methods for inflammations and cancer. For a healthy...

2013-03-11 08:26:46

LUND, Sweden, March 11, 2013 /PRNewswire/ -- NeuroVive, a leading mitochondrial medicine company, announces it has completed the acquisition of a portfolio of novel cyclophilin inhibitors, technology platform assets and related intellectual property rights from the UK biotech company Biotica Ltd. The acquisition of these assets is important strategically as it will allow NeuroVive to broaden and deepen its pipeline of novel mitochondrial medicines. No financial details of the...

2013-03-08 08:22:39

- NR is a Newly Discovered Vitamin and is a Natural Metabolite of Niacin (Vitamin B3) - IRVINE, Calif., March 8, 2013 /PRNewswire/ -- ChromaDex Corporation(®) (OTCQB: CDXC), an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, animal health, cosmetic and pharmaceutical industries, and marketer of its branded, patented pterostilbene, pTeroPure(®), announced today...

2013-02-26 08:29:03

Amidst new questions surrounding the use of antioxidant supplements, this supercharged nutrient emerges as the healthy choice for anyone over age 40 PASADENA, Texas, Feb. 26, 2013 /PRNewswire/ -- In a recent discussion within the nutrition and healthcare community last week regarding the use of antioxidant supplements, leading healthcare professionals including Dr. Mehmet Oz, Holly Lucille, N.D., Bryce Wylde, N.D., and Tasmeen Bhatia, M.D., touted Ubiquinol, a natural converted form...

2013-02-22 12:23:03

500th XF Data Reference in Elsevier: Cell Stem Cell BILLERICA, Mass., Feb. 22, 2013 /PRNewswire/ -- Seahorse Bioscience, the leader in instruments and assay kits for measuring cell metabolism, announced a new milestone: the 500(th) journal reference including XF assay data. The paper, titled BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells, will be published in the March 7, 2013 issue of the journal Cell Stem Cell....

2013-02-15 12:23:08

LA JOLLA, Calif., Feb. 15, 2013 /PRNewswire-USNewswire/ -- Doctors currently struggle to determine whether a breast tumor is likely to shift into an aggressive, life-threatening mode--an issue with profound implications for treatment. Now a group from The Scripps Research Institute (TSRI) has identified a mechanism through which mitochondria, the powerhouses of a cell, control tumor aggressiveness. Based on their findings, the team developed a simple treatment that inhibits cancer progression...

2013-02-01 08:25:12

LUND, Sweden, February 1, 2013 /PRNewswire/ -- NeuroVive, a leading mitochondrial medicine company, is pleased to announce the appointment of Jan Nilsson as Chief Operating Officer (COO). Jan will oversee the day-to-day operations of the Company and support the planned commercialisation of CicloMulsion(R) and NeuroSTAT(R), NeuroVive's leading products for the treatment of acute cardiovascular and neurological conditions through mitochondrial protection. Jan has over 30...

2013-01-29 16:47:00

Researchers at the University of Granada have produced for the first time in the world mice lacking the coenzyme Q10, a rare mitochondrial disease prevailingly affecting children. The researchers needed three years to complete the study. At three to six months of life, this genetic alteration in mice —similar to that occurred in human— causes a rapid degeneration in the lower limbs to death for cardiac arrest. For the first time in the world, researchers at the Center for...